Charles River Laboratories International, Inc. (CRL) stock analysis

In our weekly check, Charles River Laboratories International, Inc. is graded C (A to F). Of 24 checks on debt, profit, cash flow and trend: 11 pass, warnings: 8, red flags: 5.

About Charles River Laboratories International, Inc.

Charles River Laboratories International, Inc. is a Healthcare company (Diagnostics & Research) based in the United States, listed on NYSE as CRL.

What our checks show for CRL

Red flags

Warning signs

Strengths

Similar companies

RVTY · ICLR · MEDP · GH · QGEN · DGX

Questions

What grade does Charles River Laboratories International, Inc. (CRL) have?

In our weekly check, Charles River Laboratories International, Inc. is graded C (A to F). Of 24 checks on debt, profit, cash flow and trend: 11 pass, warnings: 8, red flags: 5. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of CRL stock?

This week's biggest flags for Charles River Laboratories International, Inc.: High debt, Margins falling, Gross margin falling. In total 13 of 24 checks show a warning or a red flag.

What does Charles River Laboratories International, Inc. do?

Charles River Laboratories International, Inc. is a Healthcare company (Diagnostics & Research) based in the United States, listed on NYSE as CRL.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis